| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 614.20M | 525.19M | 585.39M | 344.33M | 381.71M |
| Gross Profit | 155.66M | 164.93M | 223.31M | 136.79M | 116.83M |
| EBITDA | 273.11M | 191.36M | 253.06M | 70.25M | 93.56M |
| Net Income | 58.66M | 81.85M | 145.17M | 37.54M | -549.62M |
Balance Sheet | |||||
| Total Assets | 1.56B | 1.30B | 1.04B | 784.15M | 665.07M |
| Cash, Cash Equivalents and Short-Term Investments | 238.90M | 220.24M | 129.94M | 324.92M | 400.62M |
| Total Debt | 84.11M | 101.23M | 5.32M | 7.43M | 3.10M |
| Total Liabilities | 349.53M | 290.63M | 123.10M | 82.30M | 81.83M |
| Stockholders Equity | 1.21B | 1.01B | 915.22M | 701.85M | 583.25M |
Cash Flow | |||||
| Free Cash Flow | 238.75M | -117.07M | -119.12M | -75.08M | 80.95M |
| Operating Cash Flow | 238.87M | 292.24M | 255.23M | 164.17M | 81.68M |
| Investing Cash Flow | -387.90M | -304.95M | -517.97M | -200.92M | -233.59M |
| Financing Cash Flow | 123.49M | 107.12M | 67.23M | -2.63M | -2.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$240.10B | 6.69 | 21.02% | 0.41% | 17.19% | 94.71% | |
70 Outperform | HK$33.83B | 11.59 | 11.12% | 0.79% | 14.21% | 10.38% | |
66 Neutral | HK$99.93M | 160.47 | 0.78% | 4.55% | 32.99% | -94.85% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$240.43M | 3.55 | 5.15% | ― | 16.98% | -30.25% | |
56 Neutral | HK$80.00M | 8.39 | 16.42% | ― | 48.36% | -16.82% | |
55 Neutral | HK$398.00M | 10.88 | 12.44% | ― | -1.97% | -57.63% |